Treatment of PD-1 Inhibitor-Associated Toxic Epidermal Necrolysis: A Case Report and Brief Review.

Yidong ZhaoYuzhen CaoXiuyu WangTianyi Qian

Published in: OncoTargets and therapy (2022)

Because of the high mortality of grade four immune related adverse event (irAE) on skin, we recommend early monitoring and recognition of symptoms. During management, high-dose glucocorticoids with combined intravenous immune globulin and supportive care may be helpful.

Keyphrases

high dose
low dose
healthcare
stem cell transplantation
palliative care
wound healing
cardiovascular events
quality improvement
risk factors
soft tissue
sleep quality
adverse drug
chronic pain
drug induced
electronic health record